未登录

D

Dariusz Maciej Pisklak

medical university of warsaw

H指数:17

被引数:941

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success

癌症纳米医学的转化悖论：临床成功中的生物学、药代动力学和制造障碍

IF3.5

2026-09-050

OA

Rational Design of Novel Isosteviol-Derived Factor Xa Inhibitors Using Integrated QSAR, Molecular Docking, Molecular Dynamics, and MM/GBSA Analyses

基于QSAR、分子对接、分子动力学和MM/GBSA分析的新型同源异戊烯酸衍生物凝血因子Xa抑制剂的理性设计

IF3.5

2026-08-230

OA

Flavonoids as Modulators of the p53–Bcl-2 Axis in Cancer: Molecular Mechanisms and Therapeutic Implications

黄酮类化合物作为癌症中p53–Bcl-2轴的调节剂：分子机制与治疗意义

IF5.5

2026-06-150

OA

Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from Raja porosa

棘腹鲼来源新型海洋基杂合肽的受体结合、功能活性和细胞活力评估

IF5.4

2026-05-160

OA

The Pyrazole Scaffold in Anticancer Drug Discovery: A Review of Synthetic Approaches, Structure–Activity Relationships, and Target-Based Mechanism of Action

吡唑骨架在抗癌药物发现中的应用：合成方法、构效关系及靶点作用机制的综述

International Journal of Molecular Sciences

IF4.9

2026-04-100

OA

Crystal Structure Prediction of a Low-Symmetry Molecular Crystal (P1, Z = Z′=1) Using Periodic DFT and Cubic Starting Cells: A Case Study on 1-{4-[(prop-2-yn-1-yl)oxy]phenyl}ethan-1-one

低对称性分子晶体（P1，Z = Z′=1）的晶体结构预测：基于周期性DFT和立方起始晶胞的案例研究，研究对象为1-{4-[(丙-2-炔-1-基)氧]苯基}乙酮

Crystal Research and Technology

IF1.9

2026-04-010

PRE

Mechanistic Insights into SAM-Dependent Methyltransferases: A Review of Computational Approaches

SAM依赖型甲基转移酶的机制洞察：计算方法综述

International Journal of Molecular Sciences

IF4.9

2026-03-030

OAAI

Solid-state structure and physicochemical characterization of the hydrocortisone–β-cyclodextrin inclusion complex

氢化可的松–β-环糊精包合物的固态结构与理化表征

Journal of Molecular Structure

IF4.7

2026-02-070

PRE

A Combined Experimental and Theoretical Study of Chroman-6-ol α- and β-O-Glucosides: Dynamic Solution NMR, Solid-State NMR, Single-Crystal X-Ray Diffraction, and Density Functional Theory Calculations

对Chroman-6-ol α-和β-O-葡萄糖苷的实验与理论研究：动态溶液NMR、固态NMR、单晶X射线衍射及密度泛函理论计算

IF2.8

2025-12-010

PRE

Green chemistry meets theoretical chemistry – comparison of 24 quantum chemical methods for calculating NMR shielding constants using the RGB model

绿色化学与理论化学的交汇——基于RGB模型比较24种量子化学方法计算NMR屏蔽常数

Sustainable Chemistry and Pharmacy

IF5.8

2025-09-190

OAAI

A Pilot Study on Qualitative Metabolomics to Characterize Lewis Lung Carcinoma in Mice

IF3.4

2025-01-290

OAAI

Thiamine and Thiamine Pyrophosphate as Non-Competitive Inhibitors of Acetylcholinesterase-Experimental and Theoretical Investigations

硫胺素和硫胺素焦磷酸盐作为乙酰胆碱酯酶的非竞争性抑制剂-实验和理论研究

IF4.6

2025-01-191

OAAI

Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2025-01-010

PRE

Crystal Structure of Ritonavir Polymorphs I and II Revisited with the Application of NMR Crystallography

IF3.4

2024-12-090

PRE

17-β-Estradiol-β-Cyclodextrin complex as an aqueous solution: Structural and physicochemical characterization supported by MM and QM calculations

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2024-10-011

PRE

Opioid/Dopamine Receptor Binding Studies, NMR and Molecular Dynamics Simulation of LENART01 Chimera, an Opioid-Bombesin-like Peptide

阿片样物质-蛙皮素样肽LENART01嵌合体的阿片/多巴胺受体结合研究，NMR和分子动力学模拟

IF4.6

2024-01-043

OAAI

Density Functional Theory and Density Functional Tight Binding Studies of Thiamine Hydrochloride Hydrates

IF4.6

2023-11-091

OAAI

The Reaction Mechanism of Loganic Acid Methyltransferase: A Molecular Dynamics Simulation and Quantum Mechanics Study

洛根酸甲基转移酶的反应机理: 分子动力学模拟和量子力学研究

IF4.6

2023-07-303

OAAI

17-β-Estradiol-β-Cyclodextrin Complex as Solid: Synthesis, Structural and Physicochemical Characterization

IF4.6

2023-04-2610

OAAI

Solid state 13C NMR spectroscopy as a tool for identification of counterfeit Viagra tablets and guide for develop new identification approach of falsified product

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-04-013

PRE